September 17, 2024 06:03 GMT
HEALTHCARE: Johnson & Johnson (JNJ: Aaa/AAA neg): Trial win
HEALTHCARE
- Marginally positive: JNJ wins Oregon trial
- $260m talcum-powder verdict is overturned in company’s favour
- Separately, the bigger issue for JNJ is the $9bn class action lawsuit
The company has >75% support from claimants to proceed with settlement
37 words